Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02677285
Other study ID # R150095
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 2016
Est. completion date June 2018

Study information

Verified date June 2018
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study consists of two clinical series. With the first series investigators monitor the healing of skin grafts with bioimpedance measurements. The bioimpedance measurement is done with a purpose built patch that has electrodes in contact with the wound and reference electrodes.

In the second series the investigators monitor closed operational wounds (breast reconstruction surgery patients) with bioimpedance measurements. This series is also conducted with bioimpedance measurements but the wounds are operational wounds.

Both groups will have 20 patients.


Description:

Objectives of the study:

1. The investigators will study how bioimpedance measurement results correlate with conventional wound healing monitoring.

2. The investigators will seek the best methods for handling, interpreting and presenting bioimpedance measurement results.

3. The investigators will find out if impedance measurement is applicable to clinical use.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 40
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients that have a skin graft operation made as part of their treatment

- patients that have breast reconstruction surgery made as part of their treatment

Exclusion Criteria:

- pregnancy

- patients with limited capacity to understand the information regarding the study

- patients with chronic skin disease on operation area

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Different type of wound


Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (5)

Lead Sponsor Collaborator
Tampere University Hospital Åbo Akademi University, Tampere University of Technology, Turku PET Centre, University of Tampere

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bioimpedance data Bioimpedance values between selected measuring points with different frequencies 2 months
See also
  Status Clinical Trial Phase
Completed NCT02210208 - A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients. N/A
Completed NCT05646121 - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Not yet recruiting NCT04532593 - Autologous Adipose Stem Cell Assisted Skin Graft N/A
Completed NCT05907915 - Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery N/A
Active, not recruiting NCT04828304 - PLASOMA Ultimate Safety & Efficacy Study N/A
Active, not recruiting NCT04664738 - PEP on a Skin Graft Donor Site Wound Phase 1
Completed NCT02543034 - Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site N/A
Recruiting NCT02185950 - The Effects of Therapeutic Resources on Structure and Function of Normal and Burned Skin N/A
Completed NCT00856934 - Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing Phase 1
Recruiting NCT02090361 - Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts Phase 3
Completed NCT04754048 - Confirm the Safety and Performance of Avance Solo NPWT System N/A
Terminated NCT03992820 - Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia N/A
Recruiting NCT05600634 - Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
Withdrawn NCT01349894 - SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)